{"entity":{"type":"insider","cik":"0001892154","url":"/insider/0001892154","json_url":"/insider/0001892154.json","name":"TOI HC I, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":68,"n_filings":24,"first":"2022-08-16","last":"2024-01-30","span_basis":"filed_date"},"name_variants":[{"name":"TOI HC I, LLC","source":"filing","n_filings":24,"first_seen":"2022-08-16","last_seen":"2024-01-30"}],"transactions":[{"id":3070954,"accession":"0000950170-24-009050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-009050","line_url":"/filing/0000950170-24-009050#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8637.0,"shares_display":"8,637","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":18310.44,"total_display":"18,310.44","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-30","scope":"insider"},{"id":2299986,"accession":"0000899243-24-000121","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-24-000121","line_url":"/filing/0000899243-24-000121#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6979.0,"shares_display":"6,979","price_per_share":2.14,"price_display":"2.14","price_state":"stated","total_value":14935.06,"total_display":"14,935.06","shares_owned_after":8637.0,"shares_owned_after_display":"8,637","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-26","scope":"insider"},{"id":2299983,"accession":"0000899243-24-000121","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-24-000121","line_url":"/filing/0000899243-24-000121#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11882.0,"shares_display":"11,882","price_per_share":2.07,"price_display":"2.07","price_state":"stated","total_value":24595.74,"total_display":"24,595.74","shares_owned_after":15616.0,"shares_owned_after_display":"15,616","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-26","scope":"insider"},{"id":2299979,"accession":"0000899243-24-000121","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-24-000121","line_url":"/filing/0000899243-24-000121#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24915.0,"shares_display":"24,915","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":57304.5,"total_display":"57,304.50","shares_owned_after":27498.0,"shares_owned_after_display":"27,498","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-26","scope":"insider"},{"id":3198598,"accession":"0000899243-24-000108","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-24-000108","line_url":"/filing/0000899243-24-000108#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5338.0,"shares_display":"5,338","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":11263.18,"total_display":"11,263.18","shares_owned_after":52413.0,"shares_owned_after_display":"52,413","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-23","filed_date":"2024-01-23","scope":"insider"},{"id":3198594,"accession":"0000899243-24-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-24-000108","line_url":"/filing/0000899243-24-000108#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10263.0,"shares_display":"10,263","price_per_share":2.12,"price_display":"2.12","price_state":"stated","total_value":21757.56,"total_display":"21,757.56","shares_owned_after":57751.0,"shares_owned_after_display":"57,751","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-22","filed_date":"2024-01-23","scope":"insider"},{"id":3198587,"accession":"0000899243-24-000108","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-24-000108","line_url":"/filing/0000899243-24-000108#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11986.0,"shares_display":"11,986","price_per_share":2.13,"price_display":"2.13","price_state":"stated","total_value":25530.18,"total_display":"25,530.18","shares_owned_after":68014.0,"shares_owned_after_display":"68,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-19","filed_date":"2024-01-23","scope":"insider"},{"id":6841818,"accession":"0000899243-22-035946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035946","line_url":"/filing/0000899243-22-035946#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365321.0,"shares_display":"365,321","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":851197.93,"total_display":"851,197.93","shares_owned_after":13362873.0,"shares_owned_after_display":"13,362,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-15","scope":"insider"},{"id":6503223,"accession":"0000899243-22-035588","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-035588","line_url":"/filing/0000899243-22-035588#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61281.0,"shares_display":"61,281","price_per_share":2.98,"price_display":"2.98","price_state":"stated","total_value":182617.38,"total_display":"182,617.38","shares_owned_after":13728194.0,"shares_owned_after_display":"13,728,194","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-10","scope":"insider"},{"id":6503220,"accession":"0000899243-22-035588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035588","line_url":"/filing/0000899243-22-035588#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":3.09,"price_display":"3.09","price_state":"stated","total_value":247200.0,"total_display":"247,200.00","shares_owned_after":13789475.0,"shares_owned_after_display":"13,789,475","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-10","scope":"insider"},{"id":6503216,"accession":"0000899243-22-035588","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035588","line_url":"/filing/0000899243-22-035588#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":3.24,"price_display":"3.24","price_state":"stated","total_value":87480.0,"total_display":"87,480.00","shares_owned_after":13869475.0,"shares_owned_after_display":"13,869,475","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-10","scope":"insider"},{"id":6118067,"accession":"0000899243-22-035320","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-035320","line_url":"/filing/0000899243-22-035320#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19167.0,"shares_display":"19,167","price_per_share":3.28,"price_display":"3.28","price_state":"stated","total_value":62867.76,"total_display":"62,867.76","shares_owned_after":13896475.0,"shares_owned_after_display":"13,896,475","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-07","scope":"insider"},{"id":6118065,"accession":"0000899243-22-035320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035320","line_url":"/filing/0000899243-22-035320#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50200.0,"shares_display":"50,200","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":170178.0,"total_display":"170,178.00","shares_owned_after":13915642.0,"shares_owned_after_display":"13,915,642","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-04","filed_date":"2022-11-07","scope":"insider"},{"id":6118061,"accession":"0000899243-22-035320","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035320","line_url":"/filing/0000899243-22-035320#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45500.0,"shares_display":"45,500","price_per_share":3.58,"price_display":"3.58","price_state":"stated","total_value":162890.0,"total_display":"162,890.00","shares_owned_after":13965842.0,"shares_owned_after_display":"13,965,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-03","filed_date":"2022-11-07","scope":"insider"},{"id":6841703,"accession":"0000899243-22-034844","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-034844","line_url":"/filing/0000899243-22-034844#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58500.0,"shares_display":"58,500","price_per_share":3.94,"price_display":"3.94","price_state":"stated","total_value":230490.0,"total_display":"230,490.00","shares_owned_after":14011342.0,"shares_owned_after_display":"14,011,342","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-02","scope":"insider"},{"id":6841699,"accession":"0000899243-22-034844","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034844","line_url":"/filing/0000899243-22-034844#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50272.0,"shares_display":"50,272","price_per_share":4.26,"price_display":"4.26","price_state":"stated","total_value":214158.72,"total_display":"214,158.72","shares_owned_after":14069842.0,"shares_owned_after_display":"14,069,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-02","scope":"insider"},{"id":6841692,"accession":"0000899243-22-034844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034844","line_url":"/filing/0000899243-22-034844#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41855.0,"shares_display":"41,855","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":196299.95,"total_display":"196,299.95","shares_owned_after":14120114.0,"shares_owned_after_display":"14,120,114","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-31","filed_date":"2022-11-02","scope":"insider"},{"id":6561099,"accession":"0000899243-22-034501","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-034501","line_url":"/filing/0000899243-22-034501#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52091.0,"shares_display":"52,091","price_per_share":4.84,"price_display":"4.84","price_state":"stated","total_value":252120.44,"total_display":"252,120.44","shares_owned_after":14161969.0,"shares_owned_after_display":"14,161,969","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-28","filed_date":"2022-10-28","scope":"insider"},{"id":6561096,"accession":"0000899243-22-034501","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034501","line_url":"/filing/0000899243-22-034501#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":5.09,"price_display":"5.09","price_state":"stated","total_value":178150.0,"total_display":"178,150.00","shares_owned_after":14214060.0,"shares_owned_after_display":"14,214,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-27","filed_date":"2022-10-28","scope":"insider"},{"id":6561094,"accession":"0000899243-22-034501","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034501","line_url":"/filing/0000899243-22-034501#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52500.0,"shares_display":"52,500","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":270900.0,"total_display":"270,900.00","shares_owned_after":14249060.0,"shares_owned_after_display":"14,249,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6386567,"accession":"0000899243-22-034156","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-034156","line_url":"/filing/0000899243-22-034156#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30400.0,"shares_display":"30,400","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":155040.0,"total_display":"155,040.00","shares_owned_after":14301560.0,"shares_owned_after_display":"14,301,560","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-25","filed_date":"2022-10-25","scope":"insider"},{"id":6386565,"accession":"0000899243-22-034156","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-034156","line_url":"/filing/0000899243-22-034156#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29400.0,"shares_display":"29,400","price_per_share":4.98,"price_display":"4.98","price_state":"stated","total_value":146412.0,"total_display":"146,412.00","shares_owned_after":14331960.0,"shares_owned_after_display":"14,331,960","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider"},{"id":6386562,"accession":"0000899243-22-034156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034156","line_url":"/filing/0000899243-22-034156#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":4.96,"price_display":"4.96","price_state":"stated","total_value":99200.0,"total_display":"99,200.00","shares_owned_after":14361360.0,"shares_owned_after_display":"14,361,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-25","scope":"insider"},{"id":6945319,"accession":"0000899243-22-033908","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033908","line_url":"/filing/0000899243-22-033908#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":57960.0,"total_display":"57,960.00","shares_owned_after":14381360.0,"shares_owned_after_display":"14,381,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-20","scope":"insider"},{"id":6945316,"accession":"0000899243-22-033908","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033908","line_url":"/filing/0000899243-22-033908#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17500.0,"shares_display":"17,500","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":81900.0,"total_display":"81,900.00","shares_owned_after":14393360.0,"shares_owned_after_display":"14,393,360","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-19","filed_date":"2022-10-20","scope":"insider"},{"id":6945314,"accession":"0000899243-22-033908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033908","line_url":"/filing/0000899243-22-033908#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12200.0,"shares_display":"12,200","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":56486.0,"total_display":"56,486.00","shares_owned_after":14410860.0,"shares_owned_after_display":"14,410,860","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider"},{"id":6804735,"accession":"0000899243-22-033713","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033713","line_url":"/filing/0000899243-22-033713#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8249.0,"shares_display":"8,249","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":37945.4,"total_display":"37,945.40","shares_owned_after":14423060.0,"shares_owned_after_display":"14,423,060","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-17","filed_date":"2022-10-17","scope":"insider"},{"id":6804732,"accession":"0000899243-22-033713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033713","line_url":"/filing/0000899243-22-033713#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9800.0,"shares_display":"9,800","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":44492.0,"total_display":"44,492.00","shares_owned_after":14431309.0,"shares_owned_after_display":"14,431,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-10-17","scope":"insider"},{"id":6804727,"accession":"0000899243-22-033713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033713","line_url":"/filing/0000899243-22-033713#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25200.0,"shares_display":"25,200","price_per_share":4.67,"price_display":"4.67","price_state":"stated","total_value":117684.0,"total_display":"117,684.00","shares_owned_after":14441109.0,"shares_owned_after_display":"14,441,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-13","filed_date":"2022-10-17","scope":"insider"},{"id":6291392,"accession":"0000899243-22-033524","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033524","line_url":"/filing/0000899243-22-033524#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14343.0,"shares_display":"14,343","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":67412.1,"total_display":"67,412.10","shares_owned_after":14466309.0,"shares_owned_after_display":"14,466,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-12","filed_date":"2022-10-12","scope":"insider"},{"id":6291385,"accession":"0000899243-22-033524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033524","line_url":"/filing/0000899243-22-033524#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":4.66,"price_display":"4.66","price_state":"stated","total_value":116500.0,"total_display":"116,500.00","shares_owned_after":14480652.0,"shares_owned_after_display":"14,480,652","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-11","filed_date":"2022-10-12","scope":"insider"},{"id":6291383,"accession":"0000899243-22-033524","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033524","line_url":"/filing/0000899243-22-033524#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21500.0,"shares_display":"21,500","price_per_share":4.33,"price_display":"4.33","price_state":"stated","total_value":93095.0,"total_display":"93,095.00","shares_owned_after":14505652.0,"shares_owned_after_display":"14,505,652","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-10","filed_date":"2022-10-12","scope":"insider"},{"id":6503138,"accession":"0000899243-22-033327","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-033327","line_url":"/filing/0000899243-22-033327#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14652.0,"shares_display":"14,652","price_per_share":4.63,"price_display":"4.63","price_state":"stated","total_value":67838.76,"total_display":"67,838.76","shares_owned_after":14527152.0,"shares_owned_after_display":"14,527,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-07","scope":"insider"},{"id":6503135,"accession":"0000899243-22-033327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-033327","line_url":"/filing/0000899243-22-033327#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33509.0,"shares_display":"33,509","price_per_share":4.45,"price_display":"4.45","price_state":"stated","total_value":149115.05,"total_display":"149,115.05","shares_owned_after":14541804.0,"shares_owned_after_display":"14,541,804","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-07","scope":"insider"},{"id":6503129,"accession":"0000899243-22-033327","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-033327","line_url":"/filing/0000899243-22-033327#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14060.0,"shares_display":"14,060","price_per_share":4.78,"price_display":"4.78","price_state":"stated","total_value":67206.8,"total_display":"67,206.80","shares_owned_after":14575313.0,"shares_owned_after_display":"14,575,313","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-05","filed_date":"2022-10-07","scope":"insider"},{"id":6804668,"accession":"0000899243-22-032851","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-032851","line_url":"/filing/0000899243-22-032851#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23447.0,"shares_display":"23,447","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":113717.95,"total_display":"113,717.95","shares_owned_after":14589373.0,"shares_owned_after_display":"14,589,373","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-04","filed_date":"2022-10-04","scope":"insider"},{"id":6804663,"accession":"0000899243-22-032851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032851","line_url":"/filing/0000899243-22-032851#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16765.0,"shares_display":"16,765","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":79130.8,"total_display":"79,130.80","shares_owned_after":14612820.0,"shares_owned_after_display":"14,612,820","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6804659,"accession":"0000899243-22-032851","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-032851","line_url":"/filing/0000899243-22-032851#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":51480.0,"total_display":"51,480.00","shares_owned_after":14629585.0,"shares_owned_after_display":"14,629,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider"},{"id":6503095,"accession":"0000899243-22-032266","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-032266","line_url":"/filing/0000899243-22-032266#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21000.0,"shares_display":"21,000","price_per_share":4.62,"price_display":"4.62","price_state":"stated","total_value":97020.0,"total_display":"97,020.00","shares_owned_after":14640585.0,"shares_owned_after_display":"14,640,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-09-29","scope":"insider"},{"id":6503092,"accession":"0000899243-22-032266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032266","line_url":"/filing/0000899243-22-032266#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12642.0,"shares_display":"12,642","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":59670.24,"total_display":"59,670.24","shares_owned_after":14661585.0,"shares_owned_after_display":"14,661,585","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-29","scope":"insider"},{"id":6503088,"accession":"0000899243-22-032266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-032266","line_url":"/filing/0000899243-22-032266#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14074.0,"shares_display":"14,074","price_per_share":4.69,"price_display":"4.69","price_state":"stated","total_value":66007.06,"total_display":"66,007.06","shares_owned_after":14674227.0,"shares_owned_after_display":"14,674,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-27","filed_date":"2022-09-29","scope":"insider"},{"id":6645646,"accession":"0000899243-22-032050","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-032050","line_url":"/filing/0000899243-22-032050#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7153.0,"shares_display":"7,153","price_per_share":4.57,"price_display":"4.57","price_state":"stated","total_value":32689.21,"total_display":"32,689.21","shares_owned_after":14688301.0,"shares_owned_after_display":"14,688,301","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-26","scope":"insider"},{"id":6645644,"accession":"0000899243-22-032050","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-032050","line_url":"/filing/0000899243-22-032050#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5375.0,"shares_display":"5,375","price_per_share":4.19,"price_display":"4.19","price_state":"stated","total_value":22521.25,"total_display":"22,521.25","shares_owned_after":14695454.0,"shares_owned_after_display":"14,695,454","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-23","filed_date":"2022-09-26","scope":"insider"},{"id":6645641,"accession":"0000899243-22-032050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-032050","line_url":"/filing/0000899243-22-032050#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners GP, LLC; Havencrest Healthcare Partners, L.P.; TOI HC I, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13086.0,"shares_display":"13,086","price_per_share":4.25,"price_display":"4.25","price_state":"stated","total_value":55615.5,"total_display":"55,615.50","shares_owned_after":14700829.0,"shares_owned_after_display":"14,700,829","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-22","filed_date":"2022-09-26","scope":"insider"},{"id":6443995,"accession":"0000899243-22-031553","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-031553","line_url":"/filing/0000899243-22-031553#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19629.0,"shares_display":"19,629","price_per_share":4.33,"price_display":"4.33","price_state":"stated","total_value":84993.57,"total_display":"84,993.57","shares_owned_after":14713915.0,"shares_owned_after_display":"14,713,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-19","scope":"insider"},{"id":6443993,"accession":"0000899243-22-031553","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031553","line_url":"/filing/0000899243-22-031553#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":4.5,"price_display":"4.50","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","shares_owned_after":14733544.0,"shares_owned_after_display":"14,733,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-16","filed_date":"2022-09-19","scope":"insider"},{"id":6443990,"accession":"0000899243-22-031553","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031553","line_url":"/filing/0000899243-22-031553#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68500.0,"shares_display":"68,500","price_per_share":4.55,"price_display":"4.55","price_state":"stated","total_value":311675.0,"total_display":"311,675.00","shares_owned_after":14933544.0,"shares_owned_after_display":"14,933,544","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-19","scope":"insider"},{"id":6264346,"accession":"0000899243-22-031089","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-031089","line_url":"/filing/0000899243-22-031089#line-3","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37785.0,"shares_display":"37,785","price_per_share":4.99,"price_display":"4.99","price_state":"stated","total_value":188547.15,"total_display":"188,547.15","shares_owned_after":15002044.0,"shares_owned_after_display":"15,002,044","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-14","filed_date":"2022-09-14","scope":"insider"},{"id":6264343,"accession":"0000899243-22-031089","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-031089","line_url":"/filing/0000899243-22-031089#line-2","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52500.0,"shares_display":"52,500","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":277200.0,"total_display":"277,200.00","shares_owned_after":15039829.0,"shares_owned_after_display":"15,039,829","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-13","filed_date":"2022-09-14","scope":"insider"},{"id":6264337,"accession":"0000899243-22-031089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-031089","line_url":"/filing/0000899243-22-031089#line-1","is_derivative":false,"issuer_cik":"0001705748","issuer_name":"Oncology Institute, Inc.","issuer_ticker":"TOI","issuer_name_source":null,"issuer_url":"/issuer/0001705748","owner_cik":null,"owner_name":"Havencrest Healthcare Partners, L.P.; TOI HC I, LLC; Havencrest Healthcare Partners GP, LLC","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38000.0,"shares_display":"38,000","price_per_share":5.52,"price_display":"5.52","price_state":"stated","total_value":209760.0,"total_display":"209,760.00","shares_owned_after":15092329.0,"shares_owned_after_display":"15,092,329","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-09-12","filed_date":"2022-09-14","scope":"insider"}],"next_cursor":"2022-09-12|6264337","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001799191","name":"Oncology Institute, Inc.","url":"/issuer/0001799191","role":"Ten percent owner","n_filings":24,"first_seen":"2022-08-16","last_seen":"2024-01-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001892154","retrieved_at":"2026-08-21T18:11:35+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}